The NMI is collaborating in an international project consortium named CORESMA in which clinical, epidemiological and immunological data will be collected and triangulated to assist healthcare systems in their effort to make evidence-based decisions regarding the corona crisis. The project will receive 2.7 million euros of funding from the Horizon 2020 program over a three-year period. It is led by the Helmholtz Center for Infection Research and includes institutions from Germany, the Netherlands, China, Switzerland, Nepal and the Ivory Coast.
The NMI is advancing the development of a multiplex antibody test capable of simultaneously detecting different viral proteins, which would identify possible cross-reactions with different viruses, thus demonstrating a higher level of specificity than many of the currently available antibody tests. This test will be used by the CORESMA consortium for population studies in Germany and Nepal.
The complete press release published by the HZI can be found here.